Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development

Are you an emerging or small biotech seeking to optimize the early phase development of your small molecule or biologic drug product? Join the webinar recording, available on demand that highlights important regulatory considerations that apply across the global landscape, and help accelerate your initial clinical trials.

In this webinar, our ex-agency expert panel discussed potential early phase challenges and offered strategic solutions to avoid or overcome them. 

What will you learn? 

  • Early-phase CMC strategies for biologics and small molecules
  • Essential non-clinical considerations for first-in-human (FIH) trials
  • Clinical and clinical pharmacology perspectives

Don't miss this opportunity to gain actionable insights that could advance your early phase development strategy and maximize opportunities for regulatory success.

Watch now

Return to Insights Center

Related Insights

Related Insights

Video

Overcoming asset transfer challenges during a merger and acquisition (M&A)

Oct 20, 2021

Article

8 things you need to know about eCTDs in China

Jul 1, 2022

Blog

Focusing on value drivers to reduce risk in early-stage drug development

Jan 6, 2025

Article

Expedited Pathways Comparisons - US EU CHN

Oct 19, 2021

Playbook

What emerging trends in the FDA’s most coveted designations might tell us

Feb 8, 2024

Webinar

Accelerated Early Phase Decision-Making – Insider Insights to Speed Development

Jan 7, 2025

Show more